Position: Middle QA/QAA Engineer
Company: StartupSoft
Experience required: 2y
Category: QA
English level: intermediate
Published: 2020-01-01T00:00:00+02:00

**Responsibilities**
Develop a product test strategy and execute on it for multiple features.
Develop modular, reusable and maintainable automated tests for both Web and Mobile.
Collaborate with development, design and product team members
Report clear and detailed issues to the team
Provide and act on feedback to continuously improve development and testing practices

**Qualifications and Skills**
2+ years of manual testing experience
1+ years of experience with Selenium and Appium
1+ years of experience with a programming/scripting language e.g. Python, Java, Javascript, bash, etc.
Experience using emulation software (AWS Device Farm, BrowserStack etc.)
Experience working on a SaaS product
Familiarity with Black Box/White Box testing and edge case testing
Solid understanding and experience with any Linux distribution
Experienced with UNIX command line and basic tools (grep, awk, sed)
Familiar with regular expressions
Knowledge of source control management systems (Git, Subversion, Perforce, etc...)

**Why StartupSoft?**
Work with top entrepreneurs and startups from Silicon Valley
Become an integral part of the core team — be more than someone who just writes code
Potential to receive equity in high-growth startups from California
Contribute to well-funded products with potential to impact millions
Beautiful offices in the best locations with high-end amenities (Ternopil, Lviv)
Tight-knit team with an inclusive and transparent culture
Only the latest, modern technologies
Above average salary & benefits

**About project:**
RxDefine is better healthcare, delivered online. It’s a telemedicine platform that enables pharma companies to sell their prescription products online.

Based in California, raised millions of dollars from top-tier venture capital investors in Silicon Valley
Experienced founders, started enterprise companies worth $100+ million
RxDefine grants equity to its Ukrainian team via stock options